ArticleUnited European gastroenterology journal2016

Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

Hideki Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.